Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 43 CNY -4.04%
Market Cap: 5.1B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Acrobiosystems Co Ltd
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Acrobiosystems Co Ltd
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
Acrobiosystems Co Ltd
SZSE:301080
Retained Earnings
ÂĄ378.1m
CAGR 3-Years
63%
CAGR 5-Years
65%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Retained Earnings
-ÂĄ57.7B
CAGR 3-Years
-28%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Retained Earnings
-ÂĄ1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Retained Earnings
ÂĄ8.2B
CAGR 3-Years
70%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Retained Earnings
ÂĄ10.2B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
32%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Retained Earnings
ÂĄ29.1B
CAGR 3-Years
28%
CAGR 5-Years
54%
CAGR 10-Years
47%
No Stocks Found

Acrobiosystems Co Ltd
Glance View

Market Cap
5.1B CNY
Industry
Biotechnology

ACROBiosystems Co., Ltd. engages in the development of biomedicine and bio-protein technology. The company is headquartered in Beijing, Beijing and currently employs 397 full-time employees. The company went IPO on 2021-10-18. The firm's main products are recombinant proteins and detection services, as well as kits, antibodies, fillers, culture media and other related products. The firm's main products and services are applied to research and development (R&D) and production links such as early drug discovery and verification, drug screening and optimization, development and optimization of diagnostic reagents, preclinical and clinical trials, drug production process and process control (CMC) of tumors, autoimmune diseases, cardiovascular diseases, infectious diseases and other diseases.

Intrinsic Value
48.56 CNY
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Acrobiosystems Co Ltd's Retained Earnings?
Retained Earnings
378.1m CNY

Based on the financial report for Dec 31, 2023, Acrobiosystems Co Ltd's Retained Earnings amounts to 378.1m CNY.

What is Acrobiosystems Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
65%

Over the last year, the Retained Earnings growth was 10%. The average annual Retained Earnings growth rates for Acrobiosystems Co Ltd have been 63% over the past three years , 65% over the past five years .

Back to Top